Ocular Therapeutix Announces First Patient Dosed in Phase 1 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Read more
Bellerophon Therapeutics Announces FDA Clears Initiation of Phase 3 Study for INOpulse Inhaled Nitric Oxide Therapy to Treat COVID-19 Read more
Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine Candidate in France Read more
CRISPR and Vertex announce FDA RMAT designation granted to CTX001 to treat severe hemoglobinopathies Read more
Enhertu granted Breakthrough Therapy Designation in the US for HER2-positive metastatic gastric cancer Read more
Dyno Therapeutics Emerges from Stealth to Transform Gene Therapy Using Artificial Intelligence Read more
Acer Therapeutics to Develop Emetine as Potential COVID-19 Treatment in Collaboration with NCATS Read more
Nagy Habib, Professor of Surgery and Co-founder of MiNA therapeutics will be presenting at Oligonucleotide Therapeutics and Delivery 2020 Read more
FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients Read more